rfhg_41269.1

Basic information about the TSS

---

TSS ID: rfhg_41269.1 Species: human Chr: chr2		Start: 240565289 End: 240565305 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS,CTCF-bound (EH38D3266593,EH38E2089957)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000451363.5:499 GeneID: 57140 HGNC/MGI_ID: HGNC:10079 UniProt_ID: C9JSI2 Nearer transcript ids and distances:

Gene_name: RNPEPL1 Gene_symbol: RNPEPL1 Gene_synonyms: Gene_source: HGNC:10079

TATA-Box annotation

---

Distance to TSS:	-3187
Nearest PromoterID:	NM_018226
Entrez ID:	57140
Nearest Unigene:	Hs.5345
Nearest Refseq:	NM_018226
Nearest Ensembl:	ENSG00000142327
Gene Name:	RNPEPL1
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.647059
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNPEPL1 p2@RNPEPL1 p3@RNPEPL1 p4@RNPEPL1 p5@RNPEPL1 p7@RNPEPL1
Sample		p1@RNPEPL1	p2@RNPEPL1	p3@RNPEPL1	p4@RNPEPL1	p5@RNPEPL1	p7@RNPEPL1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.68	0.97	0.78	0.00	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.27	0.81	1.01	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	4.24	0.39	0.00	0.00	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1.87	0.83	0.62	0.83	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.27	0.45	0.67	0.22	0.22	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	3.10	0.78	0.58	0.19	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	3.70	2.18	1.31	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.15	0.97	0.73	0.24	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.27	0.21	1.28	0.21	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2.32	1.74	1.16	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	5.26	2.43	0.81	0.40	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	2.03	0.81	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	52.39	0.81	8.54	4.19	1.61	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	31.87	1.35	4.36	1.65	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	49.40	0.88	6.81	2.20	2.20	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	43.26	1.26	7.29	3.52	1.51	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.07	1.31	4.37	2.40	1.31	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	32.90	0.84	5.91	1.27	2.53	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	3.20	4.27	0.00	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.20	1.50	4.51	2.11	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	30.21	1.34	4.01	0.94	1.34	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.31	1.38	5.87	2.59	0.86	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.38	0.39	4.52	1.16	1.42	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	40.28	1.70	3.64	1.21	1.94	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	38.44	2.06	5.93	1.29	1.03	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	32.60	0.63	5.38	1.27	2.22	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.92	1.65	2.20	0.00	2.20	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	46.68	1.65	3.30	2.59	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.95	0.97	3.88	2.26	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	32.39	0.54	4.16	0.90	1.81	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.61	1.67	2.09	2.72	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.26	1.76	3.32	0.98	1.17	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.70	0.84	5.06	1.06	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	20.29	0.33	2.14	0.82	1.15	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	35.34	1.50	2.24	1.31	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	42.73	1.15	4.79	1.72	0.96	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	35.56	2.04	3.27	1.64	1.84	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.26	2.42	2.82	1.41	1.21	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	39.16	0.81	3.78	2.16	1.35	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	39.37	2.64	2.40	0.72	0.00	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.82	0.94	3.06	1.18	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.35	1.90	2.34	1.02	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	41.76	1.69	4.22	1.27	1.05	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.91	2.62	4.20	1.92	1.05	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	39.35	1.81	2.61	1.81	1.61	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.23	1.63	3.26	2.79	1.86	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	49.90	2.64	4.32	2.16	0.72	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.38	2.68	2.68	2.09	2.09	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	48.11	3.35	4.55	2.39	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	34.37	2.63	2.43	1.62	1.21	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.05	1.43	2.46	1.02	2.05	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	35.36	2.89	1.33	1.78	1.11	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.16	3.90	2.84	2.13	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	26.51	2.98	2.98	0.66	2.65	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	21.81	1.68	2.52	0.00	1.68	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	0.46	0.46	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	30.14	3.24	1.30	1.94	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	36.93	2.89	7.39	0.64	0.64	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.12	0.94	1.89	1.57	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	0.71	2.12	3.53	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	28.04	1.12	2.80	3.36	2.80	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.81	3.98	3.98	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.99	1.02	2.04	0.68	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	30.87	1.30	3.57	0.97	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.24	3.90	1.77	0.35	1.42	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	22.91	2.93	4.39	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.32	1.49	3.97	0.50	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	22.99	2.35	1.41	0.00	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.22	1.99	2.98	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	29.08	0.93	3.71	0.93	1.55	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	35.77	3.06	2.45	0.92	0.00	2.45
Adipocyte - breast, donor1	11376-118A8	16.00	1.11	0.63	2.06	1.43	0.32
Adipocyte - breast, donor2	11327-117E4	27.43	1.60	1.93	2.57	2.73	1.12
Adipocyte - omental, donor1	11473-119C6	10.69	0.64	1.15	1.40	1.40	0.89
Adipocyte - omental, donor2	11474-119C7	21.68	0.75	1.49	0.75	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	23.44	1.67	1.67	1.67	1.67	1.00
Adipocyte - perirenal, donor1	11476-119C9	13.40	0.64	0.64	0.00	2.55	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	27.49	0.00	3.30	0.00	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	1.81	3.16	4.06	3.16	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	37.88	0.52	1.56	2.26	3.13	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	28.55	2.15	3.13	1.37	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	14.67	1.03	2.57	0.77	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	28.43	0.56	3.35	0.28	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	1.76	2.35	1.18	0.59	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	36.19	1.45	3.38	2.09	1.29	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	20.98	0.97	1.94	0.32	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	19.19	0.53	3.20	0.00	2.67	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	15.58	0.56	3.90	0.00	1.67	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	38.68	2.08	7.49	0.83	3.74	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	24.11	1.51	3.77	1.26	3.52	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	28.14	1.64	2.29	0.98	1.64	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	29.23	2.74	7.61	0.61	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	11.71	3.31	2.65	0.00	0.22	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	38.73	11.83	3.59	0.36	0.72	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	22.76	1.20	4.79	0.00	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.95	2.52	0.72	0.18	0.00	1.26
Amniotic Epithelial Cells, donor2	11613-122A2	13.39	1.67	0.00	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	34.31	2.47	1.44	0.41	1.64	0.21
Anulus Pulposus Cell, donor1	11248-116E6	14.65	0.34	1.03	0.34	0.46	0.23
Anulus Pulposus Cell, donor2	11463-119B5	26.94	0.49	0.73	0.00	0.73	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.48	0.90	0.90	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	11.29	0.00	3.04	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.76	0.30	1.20	0.30	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	0.00	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	1.32	1.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.67	0.65	2.92	0.00	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	0.97	0.97	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	0.59	1.19	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.05	0.75	2.64	0.38	1.13	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	0.00	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	2.51	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.84	0.66	1.81	0.33	0.82	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	12.06	0.75	1.21	0.00	0.15	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.72	0.54	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.36	0.57	0.76	0.00	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.10	0.27	1.07	0.27	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.00	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	0.17	1.16	0.17	0.33	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.72	0.17	1.20	0.00	0.86	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.62	0.49	1.94	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	18.59	1.52	1.52	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	0.00	1.71	0.00	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	13.90	0.43	1.71	0.00	0.86	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.36	1.29	3.36	0.00	1.55	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	0.94	2.35	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.83	1.61	1.61	0.32	0.00	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	0.00	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.85	0.00	2.34	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.95	0.60	1.51	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	0.00	2.38	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	9.15	1.02	0.00	0.00	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.23	0.25	0.76	0.00	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	0.64	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.79	0.86	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	14.82	0.42	1.48	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	12.47	0.58	2.32	0.29	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	15.12	0.94	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.39	1.36	1.36	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.29	0.21	2.36	0.00	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	1.80	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	0.00	3.64	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.33	0.46	1.15	0.00	0.69	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.44	0.76	1.27	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.32	0.83	1.45	0.00	0.21	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	1.53	0.92	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.99	0.48	0.48	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.30	1.55	2.00	0.00	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	8.31	0.55	0.00	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	0.26	1.32	0.53	0.53	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.08	0.00	1.45	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.77	1.60	1.60	0.00	0.12	0.49
Astrocyte - cerebellum, donor2	11580-120F5	29.27	1.03	1.71	0.00	0.68	1.54
Astrocyte - cerebellum, donor3	11661-122F5	22.02	1.05	2.73	0.63	1.05	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	20.92	0.70	4.18	0.35	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	23.30	1.13	4.37	0.00	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	27.74	1.49	5.22	0.00	1.49	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.05	0.57	2.52	0.57	0.57	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	26.94	1.63	2.13	0.13	0.75	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.39	0.91	2.50	0.00	0.57	0.34
Basophils, donor1	12241-129G9	32.43	7.85	1.57	1.05	0.78	0.00
Basophils, donor2	12242-129H1	37.52	15.51	2.16	1.44	1.08	0.00
Basophils, donor3	12243-129H2	52.04	9.55	2.94	3.82	1.76	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	14.45	1.94	3.23	0.65	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	60.81	5.94	5.94	0.91	0.91	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	0.63	2.51	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	24.33	2.08	5.20	0.83	1.04	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	16.12	1.38	2.99	1.38	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	15.48	0.36	3.06	0.00	0.18	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.73	1.03	5.05	0.00	0.21	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	10.95	0.93	5.59	0.23	0.47	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	21.11	0.64	0.96	0.00	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	25.92	7.89	0.56	3.38	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	54.75	9.84	2.23	7.42	1.11	1.86
CD14+ Monocytes, donor3	11381-118B4	65.64	12.29	3.07	2.63	2.20	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.23	4.53	7.64	6.23	4.81	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	68.99	3.79	9.48	6.44	6.44	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	82.51	3.94	11.51	8.55	9.20	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	64.90	53.05	8.82	12.43	10.70	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	44.05	31.08	3.62	5.13	7.54	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	49.75	54.01	6.87	5.45	3.08	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	37.16	23.10	2.85	6.03	2.34	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.05	10.49	0.83	5.24	1.66	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.08	13.88	1.98	13.39	0.99	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	26.63	8.62	1.37	12.14	0.78	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	32.40	9.44	1.42	2.85	1.42	0.89
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.54	5.88	0.44	5.66	0.65	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	17.79	5.85	0.94	28.80	1.64	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.56	3.17	0.00	8.45	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	9.98	3.33	27.73	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	37.19	32.87	3.12	9.67	4.91	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	22.55	18.96	1.60	2.79	2.99	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	12.28	14.99	1.67	2.50	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	31.34	17.16	2.29	18.76	1.60	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.89	13.57	0.90	2.04	1.81	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.77	14.84	0.00	5.67	1.75	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	37.93	20.17	1.61	6.19	2.69	1.08
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	42.39	14.13	2.27	3.84	3.14	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	36.61	23.57	1.26	2.52	3.79	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.19	8.82	1.10	5.88	0.73	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	4.58	0.70	3.52	1.06	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	13.60	7.46	0.00	2.19	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.38	6.28	0.52	21.27	1.39	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.45	6.69	1.49	4.46	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.61	7.98	1.29	11.86	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	17.61	7.37	0.82	1.64	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.65	6.26	0.23	1.39	0.70	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.10	3.25	0.00	0.46	0.46	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	20.05	11.33	0.44	0.44	0.44	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	30.72	18.48	0.69	0.46	2.08	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	20.15	6.93	0.22	0.00	1.08	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	55.28	10.43	1.56	0.78	0.47	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	44.53	5.24	1.22	0.87	0.87	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	39.24	5.80	2.01	2.23	1.78	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	24.50	20.67	0.00	0.00	0.51	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	28.54	23.71	1.32	1.54	2.42	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	22.32	17.69	1.26	0.63	0.63	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	30.48	2.03	2.03	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.76	0.00	0.68	0.68	3.39	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	3.11	1.04	0.00	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.38	3.73	0.53	0.53	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	32.70	2.14	0.54	1.07	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	32.29	0.70	1.40	0.70	2.81	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	32.94	4.71	0.00	0.78	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	36.91	2.64	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	37.81	2.47	0.82	2.47	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	33.37	4.35	2.18	4.35	3.63	0.00
CD19+ B Cells, donor3	11705-123B4	42.91	5.55	2.52	2.02	2.52	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	29.09	8.89	1.21	0.00	1.21	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	22.37	8.79	1.20	0.40	0.00	1.60
CD34+ Progenitors, donor1	11545-120B6	6.02	0.00	0.00	1.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	9.55	2.81	1.12	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	24.05	1.13	1.88	0.38	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.84	0.90	1.35	0.45	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	49.63	6.78	1.43	0.71	0.71	1.07
CD4+ T Cells, donor2	11306-117C1	63.07	12.86	3.06	1.22	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	61.91	13.11	4.88	0.91	3.66	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	60.49	60.49	3.32	1.28	4.85	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	80.18	84.22	3.82	3.14	4.72	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	112.68	91.13	5.46	3.16	6.04	2.59
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.40	10.43	1.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	34.41	8.43	2.11	0.00	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	49.44	3.30	3.30	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	53.33	30.93	3.32	1.88	4.19	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	106.42	67.28	6.78	5.93	10.17	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	89.95	58.36	7.90	2.10	4.03	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	44.38	31.83	0.90	0.00	1.34	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	40.88	34.24	3.14	1.05	1.75	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.60	28.60	0.88	1.76	3.08	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	41.32	18.97	2.11	1.69	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	80.41	15.79	3.12	3.95	4.78	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	70.84	19.05	6.68	1.00	4.68	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	43.51	8.70	2.18	0.54	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	41.80	9.11	1.07	0.00	1.07	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	1.79	3.59	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	62.30	35.60	3.71	2.04	3.34	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	75.60	40.72	3.68	3.25	3.25	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	117.47	65.15	7.57	7.15	8.62	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	37.41	17.70	4.04	1.01	3.03	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	40.73	15.60	3.03	0.43	1.30	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	29.20	15.25	1.74	0.87	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	57.90	22.27	5.44	1.48	2.47	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	45.24	15.69	1.85	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	60.02	11.17	2.79	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	52.34	25.75	1.94	2.49	5.82	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.80	32.15	3.68	2.21	4.66	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	27.72	18.48	3.08	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	61.60	28.65	3.94	2.86	4.66	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	13.85	6.92	0.00	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	59.91	18.01	5.89	5.89	2.62	0.98
CD8+ T Cells, donor2	11307-117C2	61.57	20.27	7.88	2.25	4.88	1.50
CD8+ T Cells, donor3	11383-118B6	71.20	11.87	4.80	2.52	2.78	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.55	4.36	1.15	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	8.87	4.07	1.92	0.00	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.75	4.38	2.46	0.27	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	9.01	4.20	1.80	0.30	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	7.92	5.76	2.88	0.24	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	9.55	3.18	2.05	0.23	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.60	3.26	1.30	0.00	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	8.16	2.63	0.79	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.74	3.75	1.64	0.00	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	9.66	3.92	2.11	0.00	1.21	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.72	3.20	1.74	0.00	1.16	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.73	2.93	1.07	0.00	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	3.06	2.19	0.00	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	8.20	6.38	2.28	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	17.16	3.73	2.24	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	11.52	5.76	2.16	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.77	2.59	1.73	0.00	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.36	3.54	1.89	0.47	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	9.19	2.54	2.22	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.30	2.77	1.85	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	6.41	4.17	0.64	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.18	3.82	3.44	0.00	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.67	3.15	4.34	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	5.29	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2.41	1.61	0.00	0.00	0.80	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	3.50	2.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	2.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	0.49	1.48	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	13.89	0.84	2.84	0.21	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	23.57	2.08	3.81	2.77	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	13.50	0.00	1.42	1.07	1.42	0.71
Chondrocyte - de diff, donor3	11410-118E6	19.57	1.14	1.82	0.68	2.28	0.91
Chondrocyte - re diff, donor2	11339-117F7	6.27	0.00	0.90	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.13	1.21	1.62	0.40	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	11.02	0.92	1.15	0.11	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	12.40	0.43	1.50	0.00	0.64	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	21.68	1.59	1.77	0.00	0.97	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.52	2.20	5.32	0.92	1.01	0.18
Corneal Epithelial Cells, donor1	11526-119I5	22.18	1.98	1.32	0.22	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	13.65	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.80	0.77	3.83	0.00	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	42.10	5.94	3.63	0.50	1.98	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.32	5.36	1.89	0.00	2.52	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	56.05	5.62	5.08	0.54	2.59	0.97
Dendritic Cells - plasmacytoid, donor1	11228-116C4	44.07	3.07	0.68	0.34	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	17.63	1.31	0.65	0.65	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.13	0.00	0.48	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	20.01	3.50	3.50	1.00	0.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	36.97	1.17	2.35	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	35.35	2.26	4.24	1.13	0.57	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	29.10	2.36	3.15	1.57	0.39	1.97
Endothelial Cells - Artery, donor1	11264-116G4	42.47	4.36	6.40	1.16	0.87	0.87
Endothelial Cells - Artery, donor2	11341-117F9	32.23	3.29	4.94	0.71	1.18	2.59
Endothelial Cells - Artery, donor3	11413-118E9	30.68	2.98	5.79	1.75	1.23	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.06	1.11	3.55	0.22	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	1.22	5.48	0.00	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	14.10	2.82	3.66	0.56	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	22.29	3.86	2.97	1.78	1.78	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	26.03	4.17	2.60	1.56	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	43.39	1.99	5.25	1.70	2.98	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	24.01	0.80	1.60	1.20	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	30.92	2.10	6.29	0.52	4.19	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	20.75	0.99	3.60	1.24	1.24	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	22.81	1.52	3.26	0.43	0.22	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.89	1.34	3.66	0.37	0.61	0.85
Endothelial Cells - Vein, donor1	11267-116G7	47.78	2.28	7.96	0.00	2.28	1.14
Endothelial Cells - Vein, donor2	11344-117G3	36.32	5.59	4.89	3.49	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	33.60	1.88	4.87	0.79	0.79	1.26
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	41.26	3.30	1.65	6.60	0.00	0.00
Eosinophils, donor3	12246-129H5	32.10	7.13	0.00	21.40	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	14.66	2.69	1.95	0.00	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	2.08	2.08	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.17	3.69	1.23	0.00	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.42	0.44	1.09	0.55	1.20	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.33	1.63	1.63	0.54	0.87	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.61	1.09	2.67	0.97	1.94	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	7.23	0.27	3.68	0.00	0.68	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	25.31	0.63	3.80	2.74	2.00	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.01	0.00	2.11	0.53	1.58	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	22.92	2.66	5.65	1.00	1.99	0.66
Fibroblast - Cardiac, donor1	11268-116G8	34.93	0.00	1.81	0.00	0.00	1.36
Fibroblast - Cardiac, donor2	11345-117G4	25.01	2.27	2.27	1.52	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	32.33	4.10	3.94	1.89	2.68	0.79
Fibroblast - Cardiac, donor4	11452-119A3	16.97	0.30	0.30	0.61	1.21	0.30
Fibroblast - Cardiac, donor5	11456-119A7	21.95	1.40	2.16	0.38	1.02	0.51
Fibroblast - Cardiac, donor6	11460-119B2	14.25	1.67	0.76	0.00	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.94	0.40	1.34	0.40	0.27	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.10	0.00	1.73	0.43	1.73	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	1.46	1.46	1.46	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	20.99	0.92	1.38	0.23	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	35.79	1.70	2.71	0.68	0.17	0.85
Fibroblast - Dermal, donor1	11269-116G9	23.71	0.70	4.23	1.88	0.94	0.70
Fibroblast - Dermal, donor2	11346-117G5	20.75	1.42	2.36	0.47	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	23.45	0.73	5.44	0.85	2.06	0.97
Fibroblast - Dermal, donor4	11450-119A1	12.77	0.57	1.02	0.23	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	16.22	1.40	1.74	0.00	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	16.40	0.97	2.27	0.00	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	18.95	0.83	2.29	0.21	0.42	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.13	2.36	3.67	3.41	3.67	0.00
Fibroblast - Gingival, donor2	11318-117D4	26.62	1.71	4.48	0.00	0.79	0.79
Fibroblast - Gingival, donor3	11394-118C8	35.77	0.58	2.51	1.16	0.39	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	2.08	4.16	2.08	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.83	0.88	2.47	2.82	3.17	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.35	2.65	2.03	0.31	0.47	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.34	1.49	1.89	1.62	1.49	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	133.74	4.23	6.70	9.88	4.23	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.51	2.49	1.61	1.32	1.75	1.17
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	23.86	1.77	2.18	1.09	1.50	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	26.98	2.19	2.96	1.21	1.32	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.51	1.61	3.52	7.04	5.43	0.73
Fibroblast - Lung, donor1	11270-116H1	57.09	1.36	5.44	4.08	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	23.87	1.49	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	39.46	1.48	5.28	0.63	0.42	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	28.32	2.50	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	1.40	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	33.03	0.00	2.52	0.56	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	32.88	0.81	0.81	0.81	0.41	2.03
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	17.46	0.19	2.52	0.19	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.67	1.67	4.70	0.46	0.46	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	28.46	0.61	1.22	0.31	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	51.52	2.67	1.14	0.00	1.91	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.49	1.08	2.43	0.81	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.40	1.04	4.41	3.71	3.36	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.26	0.88	0.88	0.22	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	35.15	2.03	1.02	0.20	0.61	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	0.67	2.67	0.67	0.00	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.12	0.40	0.79	0.00	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	11.71	0.99	1.19	0.20	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.94	0.53	1.78	0.36	0.71	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.22	0.20	1.18	0.20	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.23	0.60	0.60	0.00	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.52	0.86	0.97	0.22	0.65	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	11.64	0.76	2.02	0.00	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	22.31	0.16	0.98	1.15	1.31	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	6.42	0.60	1.60	0.20	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	12.86	0.60	1.11	0.10	0.40	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.88	1.21	1.81	0.00	0.91	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.73	0.50	1.08	0.50	0.58	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.44	0.85	1.54	0.34	1.03	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	7.55	0.33	0.33	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	13.10	0.43	0.75	0.53	0.32	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	14.34	0.67	1.52	0.17	0.51	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.49	0.16	0.78	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	14.82	6.97	3.49	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.07	2.08	0.52	0.35	1.39	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.15	0.78	0.52	0.26	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.08	2.04	0.26	0.26	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	1.53	1.53	2.30	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	0.64	1.91	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	0.86	1.43	0.57	1.71	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	14.89	1.10	3.86	2.48	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	19.64	0.91	2.05	2.05	1.60	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.62	1.19	1.59	2.77	0.99	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	13.75	0.00	1.59	2.11	1.59	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.57	0.00	1.63	1.30	0.33	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.52	0.44	1.33	0.88	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	9.75	0.28	0.28	0.14	0.57	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	9.97	0.49	1.23	0.12	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	8.33	0.54	0.00	0.81	0.54	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	18.96	1.86	0.50	1.24	0.99	1.86
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	17.30	0.97	0.55	0.14	0.83	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.37	1.42	0.41	0.20	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.70	1.37	0.68	0.68	2.28	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	21.05	2.24	1.62	0.62	0.75	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	27.54	2.19	1.53	1.97	0.44	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.03	0.89	1.48	1.48	2.66	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	15.26	1.91	2.38	0.79	1.11	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.70	2.46	2.01	0.67	1.34	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	23.99	2.42	1.21	1.01	1.01	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.89	0.85	1.53	0.85	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	24.21	3.28	1.06	1.68	2.04	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.35	3.43	1.14	5.51	4.47	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.38	3.59	2.05	4.78	3.24	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.67	1.33	1.11	1.00	1.77	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	20.38	3.41	1.16	0.92	1.50	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.56	1.43	0.41	1.02	0.82	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	26.82	0.21	1.24	1.65	1.86	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.18	1.84	1.84	0.58	0.92	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.02	2.17	2.67	0.83	1.83	2.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.80	2.20	2.42	3.09	1.76	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	33.58	0.98	2.58	1.11	2.21	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.69	3.08	4.70	0.49	1.62	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	39.45	2.25	2.89	1.60	3.21	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.88	2.84	3.60	1.04	1.71	1.52
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	44.45	3.16	3.16	1.90	1.90	2.06
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	34.67	1.52	3.65	3.34	3.95	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	29.38	2.40	3.45	1.36	2.51	1.36
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	42.81	2.85	4.83	2.63	1.54	3.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	30.02	2.24	3.37	0.56	3.93	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	32.31	4.17	3.33	0.56	2.50	1.76
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	37.70	4.81	5.35	1.87	3.21	1.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	38.86	4.28	3.98	0.31	1.68	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	33.03	3.11	4.27	0.52	1.55	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	68.85	3.80	6.51	0.27	2.71	2.98
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	37.42	3.13	3.50	0.92	2.21	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	38.82	3.07	3.73	1.10	1.32	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	93.22	3.97	4.96	2.98	1.98	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.66	1.85	2.11	0.79	1.85	1.06
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	31.68	2.02	2.22	1.01	1.41	2.22
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.97	2.80	1.78	1.78	1.27	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.17	1.19	0.60	1.00	0.60	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.32	0.62	0.92	0.00	0.31	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	9.41	0.82	0.20	0.82	0.41	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.15	1.25	0.31	0.63	0.63	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.91	0.85	0.28	0.00	0.00	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	3.69	1.84	0.46	0.00	2.31	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	0.00	2.47	2.47	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.74	1.16	1.55	1.16	1.55	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	0.00	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	3.48	0.00	1.74	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.79	1.30	0.33	0.33	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	10.71	0.41	1.24	0.82	1.65	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.35	0.56	1.12	1.40	1.96	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	14.71	1.31	1.63	1.96	1.96	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	1.68	0.84	0.00	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	15.27	2.23	0.64	1.59	2.23	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	10.87	1.70	2.38	0.34	2.04	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	14.62	0.00	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.04	1.15	0.57	0.00	1.72	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	13.32	1.78	0.59	1.78	1.78	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	27.11	3.39	1.69	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.43	0.00	0.41	0.41	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.28	2.07	0.46	1.84	0.92	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	10.76	1.15	0.77	0.77	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.71	0.98	0.65	0.98	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	20.07	2.01	4.68	4.01	4.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	13.48	0.00	0.39	1.54	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	13.35	2.05	0.68	3.08	1.71	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	2.48	2.48	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	17.46	0.94	1.42	3.77	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	15.69	1.21	1.81	0.60	1.21	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	24.42	0.51	1.53	1.02	5.60	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.76	1.99	0.40	2.79	1.60	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	12.33	0.00	0.00	0.99	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	8.26	0.00	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	9.34	1.17	0.58	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	9.22	1.32	0.88	0.44	1.32	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	4.24	0.00	0.85	0.85	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	9.55	0.60	1.19	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	12.62	0.49	0.49	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	34.93	1.25	1.25	0.00	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	55.10	0.00	3.37	2.25	3.37	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	20.62	0.63	0.95	0.63	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	13.37	0.84	0.42	0.00	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.93	1.04	3.71	0.23	0.81	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	13.34	1.01	2.87	0.17	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	8.42	1.37	2.96	0.46	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	14.87	0.66	3.17	0.11	0.98	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.54	0.86	5.80	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	9.26	0.43	2.58	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	13.82	1.25	3.24	0.25	0.75	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	0.86	2.74	0.17	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	11.85	1.28	1.92	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	66.04	4.48	6.72	6.16	6.16	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.67	0.43	5.63	1.73	1.30	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.81	0.71	2.82	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	21.07	0.73	1.45	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.32	2.10	1.75	0.00	0.52	0.70
Hepatocyte, donor1	11523-119I2	27.84	2.42	2.42	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	35.55	3.23	10.77	0.00	3.23	0.00
Hepatocyte, donor3	11684-122I1	35.59	1.23	3.68	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	10.44	0.65	0.65	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.84	1.92	1.22	0.17	0.00	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	14.96	0.69	2.61	0.14	0.14	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	9.55	12.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	81.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	4.15	16.61	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	55.06	5.01	10.01	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	48.70	2.56	12.81	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	4.57	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	3.25	16.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	30.01	3.33	11.67	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	2.65	15.88	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	28.82	0.00	7.76	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	0.00	20.95	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	32.12	0.63	9.45	0.00	2.52	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	30.93	1.55	6.19	0.00	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	56.21	3.88	9.69	0.00	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	4.83	8.05	0.00	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	0.00	0.00	0.00	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.11	4.07	8.96	0.00	0.81	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	36.10	3.36	6.30	0.42	4.62	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.13	1.61	7.23	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	25.85	2.77	2.77	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.35	2.83	6.61	0.00	0.47	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	1.81	2.72	0.00	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	31.21	0.00	9.69	1.08	1.08	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	26.68	7.62	11.43	0.00	2.54	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	36.35	1.91	10.20	0.64	1.91	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	27.34	0.00	7.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	29.99	0.71	5.71	0.71	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	6.64	9.95	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.67	1.23	5.86	0.00	1.85	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	5.27	15.80	0.00	3.51	5.27
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.82	3.48	11.82	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	81.88	0.00	19.92	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	0.00	12.97	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	57.55	7.85	7.85	0.00	1.74	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	65.24	6.75	15.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	3.48	10.45	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	66.14	8.53	10.67	0.00	3.20	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	44.33	2.77	13.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	0.00	11.40	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	42.34	2.76	13.81	0.00	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	66.56	6.05	6.05	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	54.98	3.17	5.29	0.00	4.23	3.17
Keratinocyte - epidermal, donor1	11272-116H3	17.30	1.47	2.45	0.73	1.06	0.33
Keratinocyte - epidermal, donor2	11349-117G8	21.08	2.34	1.76	0.00	2.93	0.59
Keratinocyte - epidermal, donor3	11421-118F8	17.13	1.23	2.18	0.00	0.19	0.47
Keratinocyte - oral, donor1	11251-116E9	15.89	1.14	1.14	0.00	0.11	0.68
Keratocytes, donor1	11527-119I6	16.16	0.00	2.06	0.00	0.00	0.34
Keratocytes, donor2	11607-120I5	11.72	1.17	5.86	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	23.32	1.58	2.96	0.99	0.79	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	10.99	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	15.10	3.24	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	24.10	1.27	1.96	0.23	0.46	0.69
Lens Epithelial Cells, donor3	11690-122I7	13.62	0.61	1.61	0.00	0.20	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.27	3.44	3.08	0.95	0.47	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.26	1.40	1.40	0.28	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.88	1.57	2.68	0.94	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	2.15	2.15	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	16.70	2.21	1.26	0.32	1.26	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	18.00	2.05	3.13	0.43	1.40	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	1.64	2.87	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.73	2.78	2.53	0.25	0.76	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.72	1.55	2.39	1.13	1.69	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.47	1.19	3.56	0.00	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.78	1.55	1.94	0.39	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	20.55	1.48	1.85	0.56	2.04	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	14.63	1.05	1.39	0.70	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	20.99	1.43	3.34	0.48	1.67	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.82	1.92	2.75	0.27	1.24	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	12.01	1.23	1.85	0.31	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.90	1.25	0.62	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.69	2.74	2.01	0.55	2.01	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	16.78	2.63	4.28	0.00	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.67	1.46	4.10	0.29	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.66	2.24	4.98	0.75	2.49	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	13.58	3.39	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.73	1.35	2.15	0.27	0.54	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.38	1.51	3.03	0.45	1.97	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	11.92	1.56	1.04	0.52	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	18.22	1.47	1.47	0.21	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	21.35	1.65	1.95	0.90	1.50	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	2.06	1.38	0.69	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.18	1.88	3.01	0.75	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.95	1.70	2.86	0.64	1.59	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.60	0.00	2.91	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	1.98	1.98	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.56	2.60	2.85	0.99	1.73	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	20.73	1.85	4.07	0.37	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.11	1.24	1.73	0.25	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.75	2.47	3.44	0.55	0.96	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	18.01	1.61	1.61	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.52	1.22	0.91	0.91	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.53	1.12	0.98	0.84	1.26	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.44	1.78	2.84	0.36	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	15.03	0.97	1.94	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.87	1.71	1.24	0.47	1.87	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.91	0.72	0.72	0.00	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.99	1.31	1.63	0.65	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	20.95	1.41	2.83	0.47	1.41	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	21.29	3.47	3.71	0.62	0.74	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	14.86	1.79	2.82	0.26	1.28	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.06	1.79	2.09	0.60	1.49	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	15.86	2.27	6.80	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	1.53	3.07	0.00	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	0.74	0.74	0.00	2.97	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	22.00	2.12	2.96	0.00	1.27	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	25.32	2.11	2.11	0.70	2.81	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	31.75	2.80	1.87	0.00	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	0.52	4.64	0.00	1.55	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	32.12	2.38	1.19	0.00	2.38	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.01	2.04	1.58	0.23	1.58	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	1.74	2.04	0.58	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.06	2.25	3.60	0.00	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	27.77	1.76	2.57	0.54	2.30	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	23.11	2.57	2.57	0.51	0.51	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	23.29	2.82	1.41	0.71	1.06	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	18.66	3.33	4.66	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.92	1.02	2.55	0.00	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.61	2.13	1.60	0.00	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	18.33	1.70	1.13	0.00	1.13	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	21.47	3.07	2.45	0.00	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	28.54	1.63	5.71	0.00	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.83	1.87	1.87	0.21	1.25	1.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.54	1.12	3.36	0.00	1.40	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	28.85	3.09	2.06	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	17.42	2.03	2.32	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.95	0.30	1.79	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	1.66	2.77	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.63	1.06	4.60	0.35	1.77	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	22.50	2.21	4.79	0.00	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	25.33	2.30	6.91	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.96	2.30	2.69	0.00	1.54	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	17.55	2.83	2.26	0.00	1.70	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	22.97	1.64	0.82	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.95	1.81	3.62	0.45	2.71	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	19.39	0.72	2.15	0.72	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	4.48	2.24	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.95	1.49	2.97	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.08	0.43	3.88	0.43	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	27.40	1.71	1.71	0.86	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	23.32	2.67	2.67	0.00	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	2.41	3.02	0.60	1.81	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.28	0.71	6.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.65	1.72	5.16	0.34	1.37	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.71	0.00	2.15	0.54	3.22	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	2.69	5.39	0.00	2.69	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	22.59	2.96	1.11	0.00	2.22	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	19.77	2.33	4.65	0.00	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	28.56	2.12	6.35	3.17	3.17	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	25.61	3.60	4.00	0.80	1.60	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	23.99	0.73	2.91	0.00	2.91	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	31.43	0.77	2.30	0.00	5.37	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	24.66	1.48	4.44	0.49	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	14.11	1.88	3.76	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	26.65	1.51	3.02	0.00	3.02	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	19.38	1.80	4.96	0.00	1.80	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	0.00	5.16	1.72	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	30.28	3.56	3.12	0.89	1.34	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	27.76	3.52	2.74	0.39	1.96	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	0.00	4.62	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	1.56	5.71	0.00	2.08	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.75	2.19	1.31	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.65	0.00	3.91	0.56	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.38	2.65	5.30	0.44	2.21	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.14	2.31	3.86	0.00	0.00	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	17.22	1.52	2.53	0.00	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	24.99	1.92	2.88	0.00	1.92	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	1.19	5.17	0.80	2.78	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	19.44	1.82	4.86	0.00	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	18.68	1.38	2.08	0.69	2.08	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.24	2.28	3.80	0.00	1.90	2.66
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	2.58	2.58	0.00	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	20.56	4.23	3.63	0.00	2.42	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.96	0.63	2.85	0.63	0.95	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	3.73	3.73	1.07	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	19.54	2.87	4.02	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	2.57	4.11	0.51	1.03	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	4.95	3.54	0.00	2.83	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	26.10	3.40	2.84	0.00	1.13	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	22.47	0.83	4.99	1.25	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	3.13	5.48	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	25.89	2.09	2.09	0.42	1.67	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	19.98	2.32	3.25	0.00	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	1.34	2.68	0.67	2.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	0.53	5.35	0.53	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.20	2.02	3.64	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	0.00	1.84	0.00	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	2.67	5.33	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	26.78	1.71	5.70	0.00	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	11.50	3.83	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	20.79	2.19	5.47	0.00	1.09	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	20.49	1.34	5.79	0.00	0.45	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	22.88	3.38	4.16	0.00	1.30	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.21	3.98	4.64	0.00	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	6.24	16.63	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	43.99	2.05	3.65	0.68	1.14	0.68
Macrophage - monocyte derived, donor2	11313-117C8	35.60	3.49	2.02	0.18	1.65	1.10
Macrophage - monocyte derived, donor3	11389-118C3	59.64	5.90	4.59	0.79	1.44	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.66	1.06	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	10.77	0.95	0.48	0.16	0.16	0.63
Mallassez-derived cells, donor3	11930-125I4	7.64	0.56	0.69	0.28	0.42	0.28
Mammary Epithelial Cell, donor1	11273-116H4	10.46	0.90	0.70	0.30	0.40	0.30
Mammary Epithelial Cell, donor2	11350-117G9	11.58	1.74	1.45	0.00	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	30.93	1.25	3.24	0.00	0.75	1.00
Mast cell - stimulated, donor1	11487-119E2	2.03	0.00	0.00	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	44.55	2.81	8.54	4.33	7.46	1.41
Mast cell, donor2	11565-120D8	23.77	1.49	1.78	2.97	0.89	0.89
Mast cell, donor3	11566-120D9	20.04	0.90	4.05	1.35	1.35	0.23
Mast cell, donor4	11567-120E1	27.83	1.60	4.08	4.61	2.13	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	40.70	2.55	3.99	2.44	1.55	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	18.68	6.42	4.67	3.50	5.84	0.58
Mast cell, expanded, donor5	11939-126A4	43.48	1.49	10.67	3.56	5.16	0.80
Mast cell, expanded, donor8	11941-126A6	76.99	14.73	20.08	15.90	9.87	1.51
Melanocyte - dark, donor1	11502-119F8	44.28	1.79	3.78	0.40	0.80	0.99
Melanocyte - dark, donor2	11582-120F7	15.92	0.35	0.69	0.00	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	60.56	4.06	7.82	0.72	1.74	1.96
Melanocyte - light, donor1	11274-116H5	81.33	7.29	19.75	19.28	7.76	3.06
Melanocyte - light, donor2	11351-117H1	106.46	8.19	27.30	31.39	15.70	0.68
Melanocyte - light, donor3	11423-118G1	67.64	6.07	14.74	6.07	4.34	3.47
Melanocyte, donor1 (MC+1)	12641-134G4	53.94	2.92	8.95	1.15	3.44	1.77
Melanocyte, donor2 (MC+2)	12739-135I3	34.69	2.42	7.80	0.81	2.69	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	68.84	2.41	8.84	2.41	5.09	1.07
Meningeal Cells, donor1	11493-119E8	16.38	0.99	0.99	0.12	0.12	0.25
Meningeal Cells, donor2	11573-120E7	17.61	0.88	3.96	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	11.17	0.98	0.73	0.08	0.08	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.39	0.00	1.71	0.00	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	10.16	0.50	0.81	0.20	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	113.02	2.63	5.26	3.94	5.26	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	2.62	0.00	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	0.72	2.87	0.72	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.15	1.27	0.85	0.64	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	0.50	2.01	1.01	3.02	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.53	0.22	1.54	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	1.46	2.19	0.00	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	12.89	0.82	1.43	0.20	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.16	0.28	0.83	0.00	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.08	0.74	2.60	0.00	2.60	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.97	0.39	2.37	0.00	0.66	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	30.27	0.59	0.89	0.00	1.19	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	0.00	1.92	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	9.22	1.06	2.13	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	0.31	3.13	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	0.00	2.18	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	13.26	0.80	2.12	1.59	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	8.51	0.50	2.50	0.00	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	28.54	0.94	2.96	1.08	1.66	1.16
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	52.66	5.40	4.05	0.00	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	44.58	3.69	2.22	0.49	1.23	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	46.82	5.59	2.65	1.18	3.83	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	10.37	3.46	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.99	3.10	1.24	0.31	0.93	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.96	3.94	3.11	0.41	3.32	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	6.95	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	42.04	3.00	3.50	0.25	2.00	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.55	7.45	5.12	0.47	3.26	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	45.32	4.06	2.85	0.20	1.83	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	45.93	2.77	1.58	0.79	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	17.10	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	38.94	2.65	1.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.13	3.42	2.66	0.76	3.04	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	5.26	3.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.77	1.27	1.49	0.00	1.91	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	5.52	1.84	0.00	0.92	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	37.56	2.98	1.49	0.30	1.79	2.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	35.21	1.68	1.68	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	26.60	0.75	4.01	1.00	1.51	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	30.42	4.52	3.33	0.24	1.66	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	1.11	0.55	0.55	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.10	2.76	0.92	0.69	0.69	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.92	3.79	1.26	0.63	3.16	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.96	2.65	1.22	0.00	1.02	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.74	1.50	1.72	0.64	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	32.45	3.11	2.00	0.44	0.89	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.43	1.75	1.10	0.22	0.66	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	37.01	3.55	1.52	0.00	1.01	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	1.66	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	17.94	1.63	1.90	0.00	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.82	3.53	0.88	0.00	2.06	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	11.99	0.00	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	21.14	2.40	0.48	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	18.41	2.40	1.60	1.20	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	2.74	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.52	1.00	0.00	0.00	0.50	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.33	0.88	1.31	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	27.59	0.00	1.10	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	22.41	0.64	1.92	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	17.60	1.74	0.25	0.50	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	1.39	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	2.21	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.25	3.42	0.34	0.00	0.68	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	18.38	3.94	0.44	0.00	0.44	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	30.54	3.55	1.07	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.06	1.96	0.56	0.28	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.87	3.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.30	4.08	4.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.53	3.32	1.81	0.00	1.81	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	1.67	2.09	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	18.47	3.69	0.92	0.92	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	29.03	3.98	2.28	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.92	6.22	1.24	0.28	0.28	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.36	4.15	1.30	0.26	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	31.74	4.72	0.43	0.00	1.72	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	2.54	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.81	2.40	0.80	0.00	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.81	2.99	2.10	0.90	1.50	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	26.84	4.10	0.71	0.14	0.42	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.98	3.82	0.64	0.96	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	32.06	6.63	1.55	0.44	0.88	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.06	5.31	0.76	0.38	0.76	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.16	2.56	0.28	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	31.95	4.92	2.46	0.49	2.46	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.24	1.96	2.61	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	20.58	2.65	0.29	0.00	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.97	5.19	0.58	0.58	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.97	4.12	1.65	1.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	19.65	2.68	1.19	0.30	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	3.77	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	1.78	1.78	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	66.37	4.93	5.91	0.66	1.31	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	51.55	1.05	1.05	0.00	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.77	4.74	2.77	0.40	1.19	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	75.44	11.18	2.79	0.00	2.79	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	50.70	3.00	2.25	0.38	3.76	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	54.60	7.19	3.73	0.00	1.60	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.90	2.38	1.24	0.45	0.34	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	67.78	4.42	7.37	0.74	4.42	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	57.16	1.83	4.40	0.73	2.20	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	6.22	6.22	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	2.67	0.00	0.00	0.00	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	0.00	3.86	0.00	7.73	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	78.78	5.05	7.07	1.01	2.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.18	1.26	1.26	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	0.00	0.00	6.52	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	19.82	1.51	2.15	0.22	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.56	2.09	1.57	1.57	1.57	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	0.67	4.00	0.00	2.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	40.07	0.83	2.92	0.00	0.42	4.59
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	23.39	0.38	2.85	0.19	0.38	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	0.00	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	0.00	4.08	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	22.60	1.26	5.44	0.00	2.93	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.24	0.23	3.02	0.00	0.93	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.10	1.35	5.94	0.27	1.08	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	35.32	0.84	2.73	2.10	0.42	1.47
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.85	0.00	4.96	1.49	2.98	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.84	0.81	2.98	0.00	1.08	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	27.66	0.00	3.85	1.13	0.91	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	39.03	0.65	5.72	0.98	0.98	1.80
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	29.34	0.55	2.00	0.73	0.91	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.57	0.53	2.65	0.00	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	27.01	0.60	7.20	0.60	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.57	0.66	2.30	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.42	0.33	4.07	0.00	1.30	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.92	0.00	2.29	0.53	0.18	1.06
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.25	0.00	2.81	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.66	0.92	3.68	0.46	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.10	0.32	2.25	0.64	1.93	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	28.63	0.34	2.41	1.03	0.69	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	0.00	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.63	0.45	2.67	0.67	0.22	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.78	0.42	1.27	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.74	0.00	2.14	0.47	0.95	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.89	0.86	1.72	0.00	1.72	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.32	0.67	2.67	0.67	2.67	2.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	1.80	1.80	0.00	0.45	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.09	0.00	0.79	0.00	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	0.93	1.86	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	0.38	1.51	0.00	1.89	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.83	0.33	1.30	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.17	1.31	1.31	1.31	0.00	4.79
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	28.49	0.90	2.71	0.00	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.99	0.00	0.00	1.76	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	26.59	1.99	1.33	0.00	0.66	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.80	0.00	2.98	0.50	1.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	22.97	2.30	2.30	0.00	0.77	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.07	0.00	0.91	0.00	0.30	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	26.52	1.55	1.11	1.11	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	0.00	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	24.39	0.61	1.22	0.00	1.83	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	1.89	2.20	0.63	1.89	2.20
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.42	0.61	3.03	0.00	2.42	2.12
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	0.00	1.58	0.00	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	0.00	1.13	1.13	1.13	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	6.58	0.75	0.99	0.00	0.37	0.37
Myoblast, donor2	11322-117D8	18.60	0.96	2.30	0.38	0.96	0.38
Myoblast, donor3	11398-118D3	12.95	1.51	1.51	0.17	0.50	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	68.15	13.86	3.79	0.73	1.75	2.63
Natural Killer Cells, donor1	11230-116C6	58.12	34.44	5.23	7.69	4.61	1.85
Natural Killer Cells, donor2	11311-117C6	64.23	27.74	6.03	6.33	8.75	1.81
Natural Killer Cells, donor3	11387-118C1	87.79	26.32	8.47	6.99	7.91	1.10
Neural stem cells, donor1	11275-116H6	18.15	1.45	4.36	3.63	1.45	2.18
Neural stem cells, donor2	11352-117H2	9.63	1.93	5.78	0.00	0.00	0.00
Neurons, donor1	11494-119E9	15.93	0.00	5.69	0.00	0.00	1.14
Neurons, donor2	11574-120E8	14.53	0.44	5.72	0.00	0.22	1.10
Neurons, donor3	11655-122E8	13.15	1.64	5.76	0.00	3.29	0.82
Neutrophils, donor1	11233-116C9	81.66	4.64	5.57	44.54	6.50	0.93
Neutrophils, donor2	11314-117C9	81.17	5.80	0.00	34.79	5.80	2.90
Neutrophils, donor3	11390-118C4	81.24	9.77	0.00	113.01	9.16	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	23.15	0.47	1.31	0.00	0.36	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	37.44	0.65	1.95	0.00	1.30	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	21.66	0.60	2.21	0.00	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	41.16	0.96	1.51	0.55	0.41	1.10
Olfactory epithelial cells, donor2	11934-125I8	39.95	2.46	2.61	0.29	0.58	0.58
Olfactory epithelial cells, donor3	11935-125I9	39.61	2.27	2.04	0.68	0.45	0.57
Olfactory epithelial cells, donor4	11936-126A1	43.24	1.27	4.09	0.49	0.88	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	22.87	7.22	3.01	0.00	1.20	1.81
Osteoblast - differentiated, donor1	11276-116H7	27.22	1.70	4.25	6.17	3.62	0.85
Osteoblast - differentiated, donor2	11353-117H3	16.00	0.00	6.86	4.57	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	31.66	0.00	6.21	2.48	3.72	0.62
Osteoblast, donor1	11277-116H8	23.84	1.17	2.15	0.98	0.78	0.78
Osteoblast, donor2	11354-117H4	16.86	1.40	1.40	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	19.55	1.24	1.42	0.18	0.36	1.78
Pancreatic stromal cells, donor1	11249-116E7	17.35	0.59	2.19	1.26	2.19	0.51
Pericytes, donor1	11491-119E6	25.37	1.22	2.23	0.67	1.11	1.45
Pericytes, donor2	11571-120E5	29.88	1.13	1.81	1.58	2.04	2.04
Pericytes, donor3	11652-122E5	23.19	1.42	3.26	0.20	0.81	1.42
Perineurial Cells, donor1	11499-119F5	14.35	1.70	2.71	0.00	0.11	1.36
Perineurial Cells, donor2	11579-120F4	19.51	0.09	0.64	0.09	0.74	1.01
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	59.92	21.67	3.82	4.78	2.55	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	42.61	15.67	4.41	3.92	2.20	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	82.83	20.71	5.82	5.05	3.75	0.52
Placental Epithelial Cells, donor1	11278-116H9	19.13	2.87	0.48	0.72	1.91	0.48
Placental Epithelial Cells, donor2	11355-117H5	34.38	5.54	4.44	3.33	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	24.54	0.79	1.18	0.98	0.39	1.18
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.97	2.53	1.27	1.58	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	12.94	2.06	0.75	2.44	3.00	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	7.18	1.57	0.52	0.00	0.26	0.26
Preadipocyte - breast, donor2	11328-117E5	20.26	2.03	2.03	0.23	1.13	0.90
Preadipocyte - omental, donor1	11468-119C1	15.77	0.96	1.70	1.07	2.34	0.32
Preadipocyte - omental, donor2	11329-117E6	20.95	1.31	1.31	0.87	2.18	0.44
Preadipocyte - omental, donor3	11403-118D8	26.64	1.43	1.58	1.29	1.00	2.01
Preadipocyte - perirenal, donor1	11469-119C2	30.51	1.97	2.95	0.00	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	37.47	0.61	1.84	3.07	0.92	2.76
Preadipocyte - subcutaneous, donor2	11356-117H6	11.16	0.18	2.12	0.18	0.71	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	23.67	0.68	3.41	1.19	2.04	0.34
Preadipocyte - visceral, donor1	11280-116I2	18.63	1.12	3.35	1.02	1.21	0.47
Preadipocyte - visceral, donor2	11357-117H7	21.17	2.30	3.22	0.92	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	19.02	0.73	1.88	0.94	1.46	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	9.96	2.26	1.51	1.21	1.21	0.45
Prostate Epithelial Cells, donor2	11331-117E8	8.12	1.08	3.66	1.08	0.81	0.14
Prostate Epithelial Cells, donor3	11404-118D9	20.09	2.02	2.76	2.57	1.71	0.61
Prostate Stromal Cells, donor1	11254-116F3	12.53	0.80	2.05	0.46	1.59	0.00
Prostate Stromal Cells, donor2	11332-117E9	20.26	0.54	1.97	0.36	0.54	0.00
Prostate Stromal Cells, donor3	11405-118E1	29.41	0.63	3.55	3.55	3.13	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	48.91	4.01	4.01	2.19	1.46	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	27.59	3.05	1.59	0.35	0.49	0.90
Renal Epithelial Cells, donor1	11517-119H5	77.10	8.62	4.57	0.00	0.51	1.52
Renal Epithelial Cells, donor2	11597-120H4	44.10	4.98	1.42	2.13	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	34.51	2.12	3.07	0.42	0.21	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	44.26	5.45	6.81	1.36	2.04	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.58	3.64	4.04	0.67	1.89	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.54	2.66	3.55	0.22	0.22	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	62.55	3.99	9.98	3.33	1.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	38.74	2.20	3.30	0.44	1.32	1.76
Renal Mesangial Cells, donor2	11598-120H5	45.14	0.63	5.02	0.63	0.63	3.76
Renal Mesangial Cells, donor3	11679-122H5	60.20	2.50	3.33	1.94	3.05	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.94	4.83	3.76	0.27	1.07	1.88
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	31.21	1.69	3.37	0.00	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	41.46	4.44	2.12	0.19	0.39	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	21.00	1.56	3.37	0.00	0.00	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.71	1.99	2.84	0.28	1.42	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	3.09	3.09	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	14.30	0.75	0.75	1.00	0.50	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.19	2.81	1.87	1.47	1.34	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	2.68	8.93	0.89	1.79	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	8.81	2.20	3.30	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	1.74	1.74	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	12.74	0.65	2.60	0.26	0.13	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.66	1.09	5.66	0.10	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	16.62	1.45	3.68	0.22	0.22	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	9.68	0.62	2.11	0.00	0.12	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.90	1.52	6.18	0.00	0.82	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	21.50	0.46	6.47	0.69	0.69	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	21.77	1.78	5.34	0.00	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.30	1.06	4.69	0.15	1.06	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	14.51	1.79	3.58	0.00	0.36	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	21.09	0.86	3.30	0.29	0.86	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.96	1.82	5.90	0.00	0.32	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.68	2.21	6.42	0.66	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.35	1.91	4.40	0.19	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	18.45	1.77	4.29	0.47	0.75	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	9.21	1.88	3.01	0.38	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.76	1.99	4.91	0.40	0.13	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	21.32	2.14	3.80	0.10	0.39	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.30	0.95	4.77	0.00	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.73	1.50	3.95	0.00	0.43	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	22.14	1.40	5.33	0.28	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.34	2.05	4.27	0.00	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	18.42	2.01	2.92	0.00	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.07	1.47	4.66	0.00	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.67	1.21	4.57	0.27	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.87	1.89	3.07	0.24	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	22.42	1.19	5.56	0.40	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.41	1.17	4.91	0.00	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.11	1.87	2.28	0.41	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	19.47	1.77	7.30	0.00	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	22.56	1.88	4.39	0.00	0.63	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.48	1.08	3.77	0.13	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.33	1.53	4.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.17	1.54	2.89	0.00	0.39	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	15.47	1.38	5.33	0.17	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.59	1.92	5.76	0.00	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	18.88	1.97	4.60	0.49	0.82	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	23.69	1.36	4.43	0.00	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.60	1.33	4.14	0.30	1.63	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.86	1.87	6.40	0.00	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.92	2.63	4.42	0.55	1.24	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.14	1.43	5.71	0.00	0.71	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	33.66	2.82	7.26	0.81	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	28.16	2.73	5.09	0.85	1.60	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	32.49	3.14	5.24	2.45	3.84	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	32.94	3.02	3.63	2.72	1.21	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.78	3.43	7.22	1.71	2.57	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	29.84	4.22	4.22	1.46	2.47	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	22.51	2.43	9.13	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	23.21	3.01	7.84	0.60	1.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.52	3.85	5.65	1.36	2.49	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	22.47	5.39	11.08	2.10	3.29	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	15.47	2.83	4.49	2.36	3.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.08	2.35	7.04	1.92	2.99	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.02	2.40	7.21	1.20	4.21	1.80
Schwann Cells, donor1	11498-119F4	35.55	3.01	2.07	0.19	0.75	0.56
Schwann Cells, donor2	11578-120F3	20.41	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	23.66	2.41	1.75	0.00	0.22	1.10
Sebocyte, donor1	11220-116B5	14.24	1.10	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	15.62	2.30	2.76	2.30	0.00	0.00
Sebocyte, donor3	11378-118B1	31.54	1.65	3.30	1.03	1.44	0.62
Sertoli Cells, donor1	11255-116F4	14.91	0.00	1.66	1.66	3.31	0.00
Sertoli Cells, donor2	11333-117F1	14.12	0.00	5.65	5.65	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.15	0.79	1.67	2.46	2.02	0.70
Skeletal Muscle Cells, donor2	11358-117H8	41.20	0.72	2.89	4.34	4.34	0.72
Skeletal Muscle Cells, donor3	11430-118G8	30.10	1.67	7.52	1.67	1.67	0.84
Skeletal Muscle Cells, donor4	11451-119A2	8.33	0.47	1.10	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	8.77	0.59	0.89	0.00	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	12.31	0.46	1.54	0.15	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	14.36	0.50	1.76	0.38	0.25	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	15.12	0.71	1.71	0.14	0.14	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.50	0.40	1.19	0.20	0.30	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	16.09	0.93	1.43	0.51	0.59	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.85	0.72	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.30	0.96	1.79	0.00	1.24	0.83
Skin - palm, donor1	10286-104F7	13.43	5.37	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.76	0.43	1.87	0.14	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	9.81	0.00	3.27	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.70	1.04	2.21	0.39	0.65	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	1.81	2.64	0.97	1.11	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	23.63	3.09	2.67	1.55	2.11	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.05	1.69	2.96	0.00	0.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	33.43	3.60	3.22	2.25	0.90	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	28.70	3.39	2.47	1.23	2.16	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.34	0.89	2.89	0.22	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	0.00	2.94	0.00	1.18	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	60.99	3.31	4.64	1.10	0.66	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.45	1.58	5.91	0.79	1.58	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	13.91	0.00	1.55	1.55	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	29.02	0.00	2.00	1.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.55	2.53	2.79	3.86	2.66	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	17.51	0.44	2.88	0.44	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	6.02	0.26	1.66	0.38	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	0.98	1.30	0.00	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.72	0.30	1.77	0.00	0.00	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.81	0.57	2.28	0.00	0.14	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.87	0.81	3.42	0.00	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.40	0.91	3.04	1.22	1.22	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	41.42	0.76	4.80	2.53	1.01	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	44.35	4.29	4.77	0.95	5.25	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	8.85	0.59	1.03	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	15.07	0.22	0.65	0.00	0.00	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	13.22	0.21	0.52	0.00	0.21	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.75	2.94	2.01	1.70	1.39	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	1.08	4.31	0.00	5.39	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.44	0.00	2.69	0.30	0.00	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.80	1.02	2.39	0.00	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.96	0.55	1.88	0.31	0.55	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.95	2.42	7.65	10.47	6.24	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.61	0.68	2.50	0.23	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	0.00	4.83	0.00	1.81	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	6.89	0.53	0.79	0.00	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.84	0.53	1.60	1.60	1.07	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	20.54	1.00	2.38	1.25	1.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	27.14	0.25	1.01	1.78	2.28	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.33	1.81	2.26	0.90	2.11	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	40.51	1.50	2.25	2.25	0.75	3.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	697.80	47.81	74.95	28.43	7.75	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	41.39	3.72	3.72	2.33	2.79	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	27.77	1.51	5.05	1.51	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.55	0.94	4.39	1.25	2.19	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	0.00	1.47	0.29	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.16	0.75	1.25	0.00	0.25	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	0.47	3.27	0.00	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	29.50	1.73	2.16	0.72	1.30	1.15
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	36.20	1.27	3.57	0.76	1.53	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.90	0.56	4.51	0.38	0.75	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	17.47	0.42	1.68	0.14	0.00	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.27	0.67	1.76	0.00	0.17	0.67
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	24.29	1.43	3.81	0.95	0.00	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	1.47	2.94	1.22	0.73	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.07	1.33	1.77	3.09	1.77	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	22.24	0.00	1.17	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	17.49	1.36	2.92	1.55	2.33	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.16	1.32	0.79	0.26	0.79	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	0.37	1.86	2.60	2.60	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.06	0.72	3.59	1.08	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.75	0.57	5.96	0.00	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.15	0.00	0.00	0.39	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.13	0.51	1.27	1.02	1.52	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	17.57	0.40	2.00	1.20	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	18.39	0.00	0.84	1.25	2.93	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	17.88	1.83	1.83	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	28.61	1.35	2.19	2.52	2.69	1.18
Synoviocyte, donor2	11368-117I9	19.28	0.84	2.51	1.01	2.18	0.67
Synoviocyte, donor3	11440-118H9	25.02	0.67	4.24	1.56	3.57	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	24.66	2.14	4.29	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	1.98	5.95	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	40.98	1.85	4.17	0.23	0.69	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	10.90	1.29	2.08	0.86	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	22.81	0.77	2.32	1.55	1.93	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	0.57	4.58	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	27.43	3.32	2.09	2.58	1.35	0.62
Urethra, donor2	10319-105A4	25.18	1.80	3.60	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	14.88	1.59	0.80	0.80	1.06	0.27
Urothelial Cells, donor2	11600-120H7	14.02	0.40	1.60	0.00	0.80	0.40
Urothelial Cells, donor3	11681-122H7	27.28	1.60	2.29	0.69	0.46	0.23
Urothelial cells, donor0	11216-116B1	17.61	1.78	1.56	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	72.96	22.24	2.67	10.68	0.89	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	88.64	15.73	2.86	27.16	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.08	17.11	2.05	17.11	2.05	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.47	16.18	3.10	2.75	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.33	18.59	1.74	3.49	0.58	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	57.27	18.74	0.00	31.24	0.00	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	60.57	17.44	0.00	17.44	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	79.42	12.78	1.83	7.30	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	9.13	0.74	0.25	0.12	0.00	0.49
Wilms' tumor cell line:HFWT	10597-108E3	15.84	0.88	4.40	0.00	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.62	1.96	3.63	0.28	0.56	0.28
achilles tendon, donor2	10292-104G4	20.67	6.20	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	16.83	2.29	2.29	0.25	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	15.32	1.86	7.89	0.00	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	18.76	1.42	1.66	0.12	0.12	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	15.51	3.54	2.72	0.27	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.30	1.97	3.09	1.12	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	16.71	1.69	2.33	0.00	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	16.88	2.45	1.36	0.54	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.93	0.00	0.88	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.59	0.82	4.49	3.68	0.41	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	47.37	1.94	3.88	0.00	0.39	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	11.22	1.66	0.92	0.00	0.55	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.43	3.95	1.39	0.23	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.35	0.78	1.29	1.04	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.43	0.88	1.75	0.00	0.00	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.66	0.46	0.00	0.00	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	8.23	0.82	2.47	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.03	3.38	1.84	0.31	0.92	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.54	2.13	1.28	0.43	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	38.21	2.43	0.30	0.00	0.91	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	34.90	2.65	1.44	0.00	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	14.03	3.12	1.78	0.67	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	23.35	1.67	3.00	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	40.88	3.72	3.72	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	17.70	4.90	1.88	0.75	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	15.70	0.87	0.44	0.00	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	0.00	7.50	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	59.11	4.24	13.66	0.47	0.94	0.71
adipose tissue, adult, pool1	10010-101C1	23.27	1.55	3.26	1.55	1.86	0.47
adipose, donor1	10184-103D4	1.17	0.00	0.59	0.00	0.59	0.00
adipose, donor2	10185-103D5	6.49	0.41	2.43	1.22	1.22	2.03
adipose, donor3	10186-103D6	19.06	1.36	2.45	0.82	1.91	1.91
adipose, donor4	10187-103D7	31.20	0.00	2.60	0.87	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	40.88	1.42	6.31	0.47	0.16	3.95
adrenal gland, adult, pool1	10081-102A9	54.57	0.00	0.00	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.34	5.07	4.67	0.40	0.67	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	47.16	2.50	3.57	0.71	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	30.60	7.88	0.93	0.00	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	34.82	3.38	1.35	1.01	1.01	1.69
amniotic membrane cells, donor3	12237-129G5	32.70	6.48	2.06	0.29	1.77	0.59
amygdala - adult, donor10196	10167-103B5	8.30	2.37	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	19.67	1.01	12.37	0.20	0.61	0.61
amygdala, newborn, donor10223	10360-105E9	7.42	0.97	4.84	0.65	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	26.36	2.55	4.71	2.29	2.04	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.80	0.88	0.00	0.88	0.22	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	12.36	0.00	4.01	0.33	0.00	1.34
aorta, adult, pool1	10052-101G7	23.14	1.18	1.57	0.59	0.20	0.59
appendix, adult	10189-103D9	32.60	3.49	5.82	2.33	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	13.07	1.72	0.34	0.34	1.72	0.00
artery, adult	10190-103E1	25.82	1.36	4.08	1.36	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	20.28	1.59	1.45	0.87	0.43	1.16
b cell line:RPMI1788	10427-106D4	16.21	1.19	1.93	0.15	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.59	2.22	0.83	0.83	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.76	3.27	3.47	0.79	0.40	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	21.09	3.85	4.69	0.67	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.57	0.56	2.24	0.56	0.00	1.12
bladder, adult, pool1	10011-101C2	15.10	0.98	2.72	1.41	0.54	0.54
blood, adult, pool1	10053-101G8	110.73	8.86	0.00	11.07	11.07	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	2.57	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	16.20	0.67	4.72	0.67	2.70	0.00
brain, adult, donor1	10084-102B3	22.55	1.03	21.53	4.10	3.08	1.03
brain, adult, pool1	10012-101C3	4.79	0.78	6.12	0.11	0.56	0.45
brain, fetal, pool1	10085-102B4	13.36	0.00	26.71	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	26.76	0.00	2.64	0.33	0.66	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	22.34	1.62	4.87	0.12	0.50	1.25
breast, adult, donor1	10080-102A8	74.50	1.89	3.16	5.68	2.53	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	14.36	3.43	2.41	0.00	0.00	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	33.09	2.47	5.88	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.45	0.46	0.23	0.00	0.23	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.66	2.42	7.50	0.00	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	8.93	1.41	10.34	0.47	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	42.44	6.78	0.66	0.33	0.22	1.09
carcinoid cell line:SK-PN-DW	10719-109I8	8.56	1.90	13.94	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.19	0.80	6.39	0.80	1.33	0.00
caudate nucleus - adult, donor10196	10177-103C6	13.82	1.15	17.27	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	14.72	0.67	7.53	0.00	0.67	0.67
caudate nucleus, adult, donor10258	10379-105H1	7.64	0.76	6.88	0.00	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	5.49	0.37	8.79	0.37	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	5.83	2.91	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	13.88	0.43	17.51	0.00	0.43	1.07
cerebellum, adult, pool1	10083-102B2	12.76	1.03	14.14	0.00	1.72	2.07
cerebellum, newborn, donor10223	10357-105E6	8.30	0.00	9.13	0.83	0.83	0.83
cerebral meninges, adult	10188-103D8	5.04	0.25	2.27	0.50	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	9.50	1.46	1.46	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	8.48	0.72	3.16	0.29	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	13.92	4.64	2.32	0.50	0.33	0.17
cervix, adult, pool1	10013-101C4	16.27	1.47	2.52	1.68	1.99	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.96	0.98	3.20	0.00	0.28	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	1.31	3.92	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	15.91	0.99	2.73	3.98	2.36	0.62
choriocarcinoma cell line:SCH	10785-110H2	9.12	0.37	0.25	0.12	0.00	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	36.05	1.19	2.85	1.42	1.19	1.19
chorionic membrane cells, donor1	12238-129G6	18.80	3.13	0.85	0.28	0.28	1.14
chorionic membrane cells, donor2	12239-129G7	24.36	2.59	2.68	1.69	2.68	0.99
chorionic membrane cells, donor3	12240-129G8	15.39	0.00	1.65	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	4.04	1.01	0.00	0.00	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.78	0.96	2.69	0.96	0.77	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	23.23	5.28	4.43	0.00	0.84	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	13.35	1.03	3.60	0.26	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	18.62	0.73	2.90	0.48	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	11.40	1.43	0.81	0.41	0.20	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	9.72	2.65	1.18	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	12.77	3.13	2.61	0.26	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	13.94	0.69	2.74	0.46	1.37	1.14
clear cell carcinoma cell line:TEN	10636-108I6	9.37	1.04	0.52	0.00	0.35	0.17
colon carcinoma cell line:CACO-2	10513-107D9	10.43	1.65	0.18	0.18	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	15.20	0.00	2.66	0.00	0.00	1.14
colon, adult, donor1	10082-102B1	57.12	3.57	4.76	3.57	3.57	2.38
colon, adult, pool1	10014-101C5	34.90	4.35	6.35	8.70	4.00	0.35
colon, fetal, donor1	10070-101I7	39.55	7.42	1.24	1.24	4.33	0.62
common myeloid progenitor CMP, donor1	12130-128D6	64.17	4.58	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.40	3.40	0.42	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.79	4.53	1.36	0.75	1.06	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	5.64	2.82	1.55	0.00	0.42	0.14
corpus callosum, adult, pool1	10042-101F6	25.98	1.33	5.42	0.66	0.55	0.77
cruciate ligament, donor2	10295-104G7	12.97	1.62	1.62	0.81	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	25.68	1.61	4.01	0.80	0.80	1.61
diencephalon, adult	10193-103E4	9.60	0.48	2.16	0.72	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.78	0.46	3.44	0.23	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	20.00	2.82	1.80	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	14.68	1.93	3.37	0.96	0.72	0.48
ductus deferens, adult	10196-103E7	25.91	1.99	3.49	0.00	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	1.44	2.88	0.00	0.00	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.07	1.47	2.21	2.94	0.00	0.74
dura mater, adult, donor1	10041-101F5	28.33	2.56	4.13	1.07	0.66	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.66	3.11	2.00	2.44	1.78	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	7.74	1.58	1.00	0.14	1.29	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	17.27	3.70	1.85	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	23.31	2.12	2.72	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	22.85	3.40	3.70	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	24.96	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	4.36	0.00	1.34	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	29.54	2.17	4.53	1.09	1.63	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.49	0.32	2.41	0.00	0.64	0.16
epidermoid carcinoma cell line:A431	10426-106D3	12.34	3.78	3.22	0.78	0.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.15	2.09	2.86	0.22	0.22	1.32
epididymis, adult	10197-103E8	17.79	1.47	2.72	0.84	0.63	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.76	3.02	5.50	0.53	0.89	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	0.00	2.36	0.39	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.33	2.23	3.41	0.00	0.13	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.44	1.97	3.94	0.20	0.59	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	17.14	2.80	3.58	0.45	0.56	0.67
esophagus, adult, pool1	10015-101C6	26.54	4.78	4.57	2.44	1.70	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	7.76	0.38	3.63	0.25	0.88	1.13
eye - muscle inferior rectus, donor1	10272-104E2	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	2.10	0.00	2.10	0.00	2.10
eye - muscle medial, donor2	10299-104H2	13.39	1.49	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	10.32	1.15	2.29	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	14.57	7.29	8.74	4.37	1.46	1.46
eye, fetal, donor1	10054-101G9	14.49	1.02	2.29	0.51	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	26.93	2.95	4.74	0.51	0.51	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	16.38	0.71	1.90	0.47	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	9.95	0.75	7.13	0.09	0.47	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	8.11	1.50	4.80	0.00	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	18.01	1.83	2.65	0.37	0.27	0.46
gall bladder, adult	10198-103E9	35.97	4.10	6.28	5.79	1.69	0.97
gamma delta positive T cells, donor1	11937-126A2	84.82	50.46	5.91	3.22	6.44	0.54
gamma delta positive T cells, donor2	11938-126A3	67.60	51.54	5.23	2.24	5.98	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.24	1.90	2.32	0.42	0.63	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	25.53	3.09	5.03	0.58	0.39	0.97
gastric cancer cell line:AZ521	10549-107H9	15.74	1.15	1.64	0.00	0.00	1.31
gastric cancer cell line:GSS	10560-108A2	21.97	2.75	0.00	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.68	1.14	1.83	0.46	0.91	0.46
giant cell carcinoma cell line:LU65	10487-107B1	5.16	0.57	2.29	0.34	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	23.23	1.96	2.80	0.70	0.84	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	23.20	5.99	5.24	0.25	1.50	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	17.21	0.95	4.12	0.53	0.32	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.08	1.26	1.69	0.14	0.14	0.98
glioblastoma cell line:T98G	10485-107A8	15.45	0.88	1.99	0.33	0.00	0.11
glioma cell line:GI-1	10413-106B8	13.77	2.05	0.88	0.88	0.29	0.59
globus pallidus - adult, donor10196	10175-103C4	16.04	0.00	8.75	0.00	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	31.24	0.73	5.37	0.49	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	6.85	1.37	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	1.07	4.80	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	48.94	4.89	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.32	1.92	1.28	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	11.02	2.75	0.46	0.46	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	4.57	0.91	0.46	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	14.81	0.64	0.64	1.29	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	9.60	0.00	0.00	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	11.03	1.10	6.62	0.00	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	12.36	0.29	1.44	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	13.15	0.90	3.59	0.30	0.00	1.49
heart - pulmonic valve, adult	10206-103F8	33.73	1.83	3.14	0.78	0.78	1.57
heart - tricuspid valve, adult	10207-103F9	21.65	3.33	3.33	1.67	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	48.77	1.63	3.47	0.82	0.82	3.26
heart, adult, diseased, donor1	10051-101G6	75.80	4.26	7.66	0.85	0.43	2.98
heart, adult, pool1	10016-101C7	27.60	2.76	2.99	3.91	1.15	1.84
heart, fetal, pool1	10046-101G1	30.39	2.77	2.57	0.92	0.41	1.75
hepatic mesenchymal tumor cell line:LI90	10778-110G4	24.68	0.93	1.85	0.31	0.93	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	16.65	0.00	0.00	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	40.11	4.97	3.31	0.33	0.22	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	34.83	5.83	5.34	0.00	0.85	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	38.80	6.37	4.65	0.40	0.61	1.31
hepatoma cell line:Li-7	10484-107A7	13.46	1.33	2.11	0.22	0.56	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	27.54	1.61	3.92	0.00	0.20	0.70
hippocampus - adult, donor10196	10169-103B7	8.52	1.89	5.68	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	21.02	1.43	11.02	0.20	1.22	1.02
hippocampus, adult, donor10258	10374-105G5	4.98	1.00	8.47	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	10.22	3.88	17.62	0.70	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	3.05	0.00	0.61	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	7.85	1.96	1.18	0.98	0.98	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	8.38	1.27	0.51	0.51	0.25	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	13.53	0.00	1.69	1.13	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	13.17	0.77	3.87	3.10	2.32	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	9.87	0.38	1.52	1.52	0.76	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	5.84	1.17	1.75	1.46	1.46	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	11.85	0.86	2.80	1.94	1.94	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	0.00	5.42	1.25	0.42	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	5.68	1.42	2.84	0.47	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	12.21	2.25	4.82	1.29	1.61	2.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.79	0.67	2.02	0.00	1.35	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	8.45	0.94	0.63	0.63	0.78	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.86	0.98	1.97	0.98	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	3.49	0.00	1.75	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	15.65	0.19	4.96	2.67	1.53	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	13.08	0.00	2.62	1.31	1.74	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	6.50	0.00	0.00	0.50	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	2.64	0.38	1.51	0.75	0.19	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	3.18	0.45	1.36	0.00	0.45	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	2.82	0.31	1.25	0.63	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.70	0.82	2.45	1.47	0.65	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.39	0.58	2.61	0.58	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	7.17	0.60	2.09	0.60	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.67	1.66	1.11	0.55	0.55	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.55	0.57	2.28	1.43	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	0.82	0.82	0.00	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.03	0.35	2.11	2.11	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	13.30	0.63	2.53	2.85	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	10.59	1.21	4.84	2.72	1.21	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.83	0.00	2.59	0.00	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	6.64	0.00	1.33	1.33	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	6.16	0.51	1.28	0.00	0.26	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.20	0.51	3.58	0.51	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	6.06	1.51	1.51	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	8.07	2.35	3.70	0.67	1.01	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	10.63	1.45	1.69	0.48	0.97	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	7.58	0.89	1.34	0.45	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.78	0.00	0.98	0.98	0.49	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	8.86	0.00	3.67	2.14	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.29	0.33	1.32	1.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.66	0.55	1.64	1.09	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.15	1.09	1.09	0.36	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	0.36	2.14	0.36	0.71	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	1.19	2.39	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.48	0.81	2.17	1.35	1.49	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.54	1.35	1.08	0.54	0.27	0.81
immature langerhans cells, donor1	11904-125F5	9.44	0.00	0.24	0.00	0.24	0.24
immature langerhans cells, donor2	11905-125F6	12.67	0.00	2.38	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	7.19	1.42	10.60	0.19	0.66	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	32.19	9.43	5.20	3.25	1.95	1.30
kidney, adult, pool1	10017-101C8	26.43	2.20	2.20	2.00	1.20	1.00
kidney, fetal, pool1	10045-101F9	18.11	1.70	1.77	0.28	0.35	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	14.63	2.56	1.56	0.43	0.43	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	22.67	3.04	3.46	0.55	1.38	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.09	1.10	2.20	0.00	0.55	0.18
left atrium, adult, donor1	10079-102A7	49.04	1.09	10.90	3.81	2.18	2.72
left ventricle, adult, donor1	10078-102A6	46.01	1.01	4.55	2.02	2.53	3.03
leiomyoblastoma cell line:G-402	10721-110A1	29.82	0.55	8.48	0.00	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	11.86	0.72	2.51	1.44	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	9.24	0.54	0.54	0.54	1.09	0.00
leiomyoma cell line:15425	10571-108B4	12.87	0.73	1.46	0.49	1.21	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	1.05	2.09	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	28.22	4.84	5.43	0.12	0.59	1.53
liposarcoma cell line:KMLS-1	10782-110G8	15.62	0.94	2.50	0.16	0.16	1.09
liposarcoma cell line:SW 872	10726-110A6	31.19	1.10	2.92	0.24	0.37	1.46
liver, adult, pool1	10018-101C9	42.30	1.62	2.43	1.62	2.43	1.13
liver, fetal, pool1	10086-102B5	35.75	0.94	5.64	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	12.40	1.60	5.40	0.58	0.29	0.58
locus coeruleus, adult, donor10252	10165-103B3	21.22	0.37	4.80	0.00	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	11.29	1.41	3.39	0.00	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	3.36	3.36	2.10	0.84	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	18.68	0.83	0.83	0.28	0.00	0.83
lung adenocarcinoma cell line:PC-14	10408-106B3	66.87	6.20	8.96	0.69	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	45.87	3.95	4.61	0.92	1.32	1.32
lung, adult, pool1	10019-101D1	25.75	3.90	3.31	2.95	1.65	0.71
lung, fetal, donor1	10068-101I5	10.85	1.71	0.29	1.71	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	58.19	6.87	9.16	11.46	8.25	1.37
lymph node, adult, donor1	10077-102A5	72.42	3.31	8.52	11.36	7.57	1.89
lymphangiectasia cell line:DS-1	10727-110A7	39.89	2.85	4.38	0.22	0.44	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	15.24	0.45	2.87	0.00	0.75	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	11.04	5.95	4.25	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	48.84	1.33	2.22	0.44	0.00	0.89
mature adipocyte, donor2	12232-129F9	37.56	1.04	1.25	2.08	2.08	0.83
mature adipocyte, donor3	12233-129G1	35.09	0.71	0.71	0.71	0.47	1.66
mature adipocyte, donor4	12234-129G2	40.01	0.53	1.32	0.79	0.79	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.97	2.62	1.43	3.81	1.43	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	3.38	1.13	10.15	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.18	1.10	10.67	0.18	0.74	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	0.95	12.39	0.00	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	1.71	0.43	3.84	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	7.93	0.68	10.46	0.00	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	14.43	0.85	15.07	0.42	0.85	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	1.93	5.78	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	5.74	3.23	8.26	0.72	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	9.73	0.00	4.54	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	18.73	1.08	4.95	0.62	0.62	0.77
medulla oblongata, adult, pool1	10038-101F2	11.51	1.14	5.31	0.16	0.41	0.57
medulla oblongata, newborn, donor10223	10361-105F1	16.32	1.74	4.17	0.00	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	17.27	1.11	2.66	0.44	0.44	0.44
medulloblastoma cell line:ONS-76	10759-110E3	12.96	1.22	3.18	0.00	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	18.40	2.87	2.30	1.58	2.16	0.72
melanoma cell line:G-361	10465-106H6	12.22	1.90	8.14	5.97	3.53	0.54
meningioma cell line:HKBMM	10691-109F7	16.82	0.72	0.90	0.18	1.09	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	2.64	8.81	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	12.18	0.26	5.18	0.00	0.52	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	12.27	0.15	0.61	0.00	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	8.36	0.18	0.73	0.18	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	0.41	1.24	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.29	0.14	1.26	0.00	0.56	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.82	0.00	1.73	0.19	0.96	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	8.33	0.00	0.69	0.00	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.36	0.00	1.37	0.17	0.69	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.65	0.23	1.73	0.00	0.81	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.49	0.27	0.93	0.13	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	7.83	0.41	1.76	0.14	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.25	0.43	1.28	0.14	0.00	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.55	0.33	1.32	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	10.10	0.69	1.25	0.14	0.28	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	15.36	0.70	2.79	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.68	0.41	1.43	0.00	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.74	1.08	1.80	2.16	0.36	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.48	0.52	1.66	0.00	0.31	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	11.63	0.23	3.88	0.46	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	2.10	0.42	0.84	0.42	0.00	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.13	0.45	0.60	0.15	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.38	0.26	1.58	0.09	0.26	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.15	0.74	1.47	0.00	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.02	1.14	2.86	0.86	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	8.84	1.68	1.26	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	0.00	0.91	0.91	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.00	1.02	1.53	0.51	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.92	1.31	1.57	0.00	0.52	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.71	1.23	0.92	0.31	1.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.30	0.71	0.47	0.47	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	0.68	2.03	0.34	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.11	1.18	1.57	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	11.58	1.85	2.32	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	1.15	2.02	0.87	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.96	1.34	2.45	0.67	0.45	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	0.72	0.72	0.72	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	1.47	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.41	0.67	0.34	0.34	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	0.41	1.23	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	3.01	2.15	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.77	0.00	0.65	0.65	0.32	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	0.00	1.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	0.00	1.07	0.53	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	0.82	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.66	1.94	0.78	0.78	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	1.99	0.00	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	2.37	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	0.00	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	0.00	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.07	0.00	1.03	1.72	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	2.15	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.63	0.00	1.63	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.83	0.00	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.99	0.59	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.46	0.00	1.25	0.62	1.25	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	21.39	0.00	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	30.75	0.00	4.73	2.37	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	2.57	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.16	0.00	1.38	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	1.98	3.46	0.99	1.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	35.89	1.12	6.73	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.89	0.00	1.91	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	60.85	2.42	8.87	0.40	3.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	47.97	4.36	10.90	0.00	4.36	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	43.08	1.27	15.20	6.34	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.66	1.21	9.10	1.21	3.03	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	63.27	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	53.54	1.65	7.41	0.82	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.22	0.79	3.77	0.00	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.58	0.32	2.27	0.32	2.60	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	0.00	6.11	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	25.53	3.09	1.55	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	26.46	6.61	2.13	0.47	0.00	2.13
mesothelioma cell line:ACC-MESO-4	10494-107B8	11.35	0.46	0.23	0.00	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	8.94	1.34	2.26	0.41	0.41	0.00
mesothelioma cell line:Mero-25	10850-111F4	10.21	1.59	0.68	0.00	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	23.23	0.98	1.22	0.00	0.73	0.98
mesothelioma cell line:Mero-48a	10852-111F6	24.80	2.88	2.44	0.89	0.66	0.66
mesothelioma cell line:Mero-82	10853-111F7	22.34	6.83	3.94	0.53	1.84	0.26
mesothelioma cell line:Mero-83	10854-111F8	13.11	1.53	3.06	1.70	0.85	0.34
mesothelioma cell line:Mero-84	10855-111F9	20.73	5.06	0.25	0.25	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	20.91	2.48	5.38	2.28	1.04	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	23.19	3.64	4.97	0.99	0.99	0.17
mesothelioma cell line:NCI-H226	10846-111E9	17.19	3.08	2.90	0.18	0.54	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	12.47	1.20	2.39	1.02	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	21.63	0.25	1.27	0.51	2.04	1.02
mesothelioma cell line:No36	10857-111G2	11.09	0.00	1.30	0.65	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	21.68	2.44	0.54	0.54	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	25.53	4.41	1.54	0.38	0.96	0.77
migratory langerhans cells, donor2	11902-125F3	23.08	5.86	0.61	0.98	0.61	0.00
migratory langerhans cells, donor3	11903-125F4	18.13	3.23	1.08	0.90	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.57	1.31	0.65	0.00	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	10.60	1.70	1.70	0.00	0.00	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.39	5.76	7.60	0.46	0.46	2.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	48.71	4.95	2.66	1.52	1.71	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	19.77	2.22	6.10	5.91	0.55	0.00
myeloma cell line:PCM6	10474-106I6	36.77	11.46	17.99	2.77	4.35	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	0.51	1.52	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	10.20	0.00	2.16	0.39	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	16.49	1.00	1.78	0.00	0.45	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.94	1.40	1.84	0.22	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	24.29	3.86	0.55	0.00	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	9.20	2.07	0.92	0.23	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	14.03	1.31	1.87	0.00	0.75	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	4.64	0.42	3.37	0.00	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	11.74	0.56	2.42	0.19	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.03	1.19	4.74	0.00	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	14.89	1.11	2.85	0.95	0.79	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	16.50	0.81	5.84	0.00	0.60	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	13.99	1.27	5.72	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	27.15	1.60	1.33	0.53	0.00	0.80
neutrophil PMN, donor1	12133-128D9	89.25	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	16.40	1.69	5.92	0.34	0.85	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	8.01	0.80	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.67	1.60	2.24	0.64	0.64	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.55	1.58	1.31	0.53	1.05	0.26
nucleus accumbens, adult, pool1	10037-101F1	9.56	0.66	7.41	0.19	0.94	0.84
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	10.30	2.06	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	21.74	1.07	17.44	0.27	0.27	1.61
occipital cortex, newborn, donor10223	10355-105E4	7.28	1.09	13.10	0.36	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	10.23	0.79	7.35	1.05	2.89	1.57
occipital lobe, fetal, donor1	10073-102A1	14.16	1.29	15.02	0.43	0.43	2.15
occipital pole, adult, pool1	10036-101E9	8.99	1.18	8.04	0.24	0.55	0.24
olfactory region, adult	10195-103E6	8.22	1.53	11.08	0.38	0.00	0.57
optic nerve, donor1	10277-104E7	32.02	0.00	14.01	2.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.69	2.73	0.23	3.19	1.37	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	18.68	2.06	2.06	0.41	0.00	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	8.97	0.68	0.51	0.00	0.34	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	26.10	1.85	1.39	0.35	0.46	1.16
osteoclastoma cell line:Hs 706.T	10704-109H2	36.16	4.41	3.23	1.47	1.47	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	40.18	12.15	8.41	0.93	3.74	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	5.73	0.85	0.42	0.00	0.21	0.64
ovary, adult, pool1	10020-101D2	12.40	0.79	2.45	0.87	0.44	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	11.37	0.55	1.65	0.18	0.00	0.55
pancreas, adult, donor1	10049-101G4	59.26	1.88	23.52	0.94	5.64	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	34.94	1.96	2.52	1.12	1.96	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	14.82	2.38	2.90	0.17	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	32.79	5.46	1.82	0.83	0.50	1.32
paracentral gyrus, adult, pool1	10035-101E8	7.05	1.01	7.78	0.09	0.92	0.27
parietal cortex, adult, donor10258	10373-105G4	19.08	0.00	2.20	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	6.58	1.88	7.52	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	16.82	0.29	13.40	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	10.40	1.50	6.96	0.35	0.26	0.70
parietal lobe, fetal, donor1	10072-101I9	22.31	0.97	12.61	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	2.62	0.37	7.85	0.37	0.37	0.37
parotid gland, adult	10199-103F1	46.25	1.23	11.72	0.00	1.23	0.00
penis, adult	10200-103F2	29.54	1.07	6.98	1.61	2.15	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.88	0.37	5.02	1.49	0.19	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	44.00	3.79	4.08	0.73	0.58	0.87
pineal gland - adult, donor10196	10179-103C8	5.16	1.29	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	9.48	0.00	2.37	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	5.02	0.00	1.88	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	2.02	1.01	4.05	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	13.55	1.56	2.08	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	6.81	0.85	6.81	0.00	1.70	0.00
placenta, adult, pool1	10021-101D3	16.77	3.44	1.51	1.51	0.65	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	14.83	1.46	1.46	0.13	0.40	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	23.81	0.78	2.18	0.93	0.93	0.78
pons, adult, pool1	10033-101E6	6.28	0.69	4.48	0.26	0.77	0.43
postcentral gyrus, adult, pool1	10032-101E5	7.67	1.05	8.63	0.00	0.44	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	2.09	2.09	10.46	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	13.40	2.18	5.10	0.15	0.29	1.02
prostate cancer cell line:PC-3	10439-106E7	19.24	1.09	7.08	0.18	0.00	0.18
prostate, adult, pool1	10022-101D4	20.31	0.82	2.45	1.45	1.18	0.54
putamen, adult, donor10196	10176-103C5	6.14	0.47	6.61	0.00	0.24	0.94
putamen, adult, donor10252	10152-102I8	5.88	0.00	5.88	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	2.19	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.94	1.93	3.38	0.24	0.72	0.72
putamen, newborn, donor10223	10365-105F5	7.50	0.00	8.25	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	8.73	1.45	1.16	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	25.04	6.95	4.17	0.00	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	10.18	0.85	1.06	0.42	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.97	0.00	1.24	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	18.49	0.50	2.98	0.40	0.80	0.30
retinoblastoma cell line:Y79	10475-106I7	1.82	1.04	1.82	0.00	0.00	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	9.34	0.49	1.72	0.12	0.12	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	9.28	1.12	3.37	0.28	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	27.28	1.52	3.03	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	17.16	0.81	1.78	0.97	0.81	0.32
salivary acinar cells, donor2	11772-123I8	19.28	2.20	4.13	1.93	2.20	0.55
salivary acinar cells, donor3	11773-123I9	42.37	3.97	2.65	1.99	0.66	0.66
salivary gland, adult, pool1	10093-102C3	30.31	1.14	5.15	0.00	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.19	0.59	2.70	0.17	0.34	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	11.40	1.06	3.53	0.59	0.47	0.24
seminal vesicle, adult	10201-103F3	20.63	0.00	7.41	2.65	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.99	1.46	0.24	0.49	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.58	1.01	1.01	0.00	1.01	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	17.06	0.00	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.92	4.84	1.61	0.13	0.54	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	12.71	6.74	4.53	0.99	1.44	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	19.74	4.64	2.32	0.39	0.77	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	0.00	2.13	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	32.14	0.96	3.24	4.08	1.92	1.68
skeletal muscle, fetal, donor1	10066-101I3	52.26	3.02	3.02	1.01	0.00	2.01
skin, adult, donor1	10074-102A2	40.71	6.79	6.79	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	14.52	0.63	0.00	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	40.36	3.67	2.33	0.67	0.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	10.72	0.63	4.10	0.32	0.63	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	11.18	0.96	4.24	0.19	0.39	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	15.99	3.96	1.65	0.33	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.83	0.00	0.16	0.00	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	37.05	6.32	9.37	0.87	1.31	0.00
small intestine, adult, pool1	10024-101D6	57.45	18.99	6.09	7.29	4.90	1.43
small intestine, fetal, donor1	10064-101I1	44.72	6.63	3.19	1.23	1.72	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	36.42	21.03	4.10	0.00	1.03	1.54
smooth muscle, adult, pool1	10048-101G3	20.68	0.52	2.33	0.26	0.26	1.29
somatostatinoma cell line:QGP-1	10781-110G7	50.39	4.29	5.09	0.54	0.54	1.07
spinal cord - adult, donor10196	10181-103D1	20.42	1.15	5.51	0.69	0.46	1.38
spinal cord, adult, donor10252	10159-103A6	23.26	1.58	2.37	0.79	0.00	1.58
spinal cord, adult, donor10258	10369-105F9	8.99	0.00	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	23.78	0.00	5.49	0.00	4.27	3.66
spinal cord, newborn, donor10223	10359-105E8	11.94	0.92	0.92	0.46	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	29.42	2.99	2.84	0.15	0.30	1.05
spleen, adult, pool1	10025-101D7	41.08	3.96	3.30	4.30	2.75	0.66
spleen, fetal, pool1	10044-101F8	29.32	3.73	2.86	1.91	0.64	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	12.32	0.72	0.72	0.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	15.57	6.27	2.66	0.95	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	22.71	3.49	1.75	0.70	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.95	1.17	0.78	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.48	1.35	1.35	0.23	0.11	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	10.59	0.85	2.12	0.42	0.00	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	20.73	0.42	0.42	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	42.72	9.61	2.14	1.07	0.00	1.07
submaxillary gland, adult	10202-103F4	23.36	0.00	7.98	0.57	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	30.74	1.04	8.52	0.42	0.00	1.25
substantia nigra, adult, donor10258	10371-105G2	8.28	0.52	5.69	0.00	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	21.90	2.83	4.24	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.71	1.15	1.38	0.46	0.23	1.60
temporal lobe, adult, pool1	10031-101E4	11.53	1.10	10.26	0.25	0.93	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	20.66	0.71	14.25	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	10.55	0.00	10.55	0.44	0.88	0.44
tenocyte, donor1	11763-123H8	26.18	0.35	1.75	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	27.09	2.29	2.29	0.38	0.76	0.38
tenocyte, donor3	11768-123I4	23.72	1.11	1.48	0.00	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	11.56	0.85	0.34	0.00	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	30.83	3.08	1.54	1.39	0.77	1.54
teratocarcinoma cell line:PA-1	10807-111A6	16.12	1.55	0.62	0.31	0.15	1.55
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.31	0.76	0.38	0.76	0.51	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.40	0.00	0.00	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	4.69	0.65	0.76	0.11	0.33	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	14.39	1.72	3.44	3.01	1.83	0.43
testis, adult, pool2	10096-102C6	9.92	1.35	6.32	0.45	2.26	0.45
thalamus - adult, donor10196	10168-103B6	8.83	1.10	8.83	1.10	0.00	2.21
thalamus, adult, donor10252	10154-103A1	18.60	0.16	6.25	0.78	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	0.00	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.58	0.82	5.43	0.33	0.00	0.33
thalamus, newborn, donor10223	10366-105F6	3.45	0.58	1.73	0.00	1.15	0.00
throat, adult	10209-103G2	17.48	4.74	3.75	0.75	0.75	0.50
throat, fetal, donor1	10061-101H7	18.59	0.30	2.44	0.61	0.30	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	13.51	1.79	5.76	0.00	0.99	0.40
thymus, adult, pool1	10027-101D9	46.82	1.99	3.48	5.27	2.88	2.29
thymus, fetal, pool1	10043-101F7	29.82	2.49	2.70	1.56	1.14	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.79	3.86	3.59	0.27	1.46	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	15.51	0.70	3.63	0.28	0.70	0.98
thyroid, adult, pool1	10028-101E1	20.16	1.31	1.87	0.75	0.75	0.47
thyroid, fetal, donor1	10060-101H6	29.79	1.05	3.69	0.26	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	6.16	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	25.12	2.79	4.88	3.02	0.70	0.23
tongue, fetal, donor1	10059-101H5	39.02	3.15	3.55	0.39	0.79	1.97
tonsil, adult, pool1	10047-101G2	26.15	5.11	4.01	1.10	1.00	0.40
trachea, adult, pool1	10029-101E2	24.78	3.52	2.70	2.86	0.98	0.08
trachea, fetal, donor1	10058-101H4	21.16	0.77	3.85	0.38	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	20.19	0.00	2.13	0.35	0.00	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	11.14	1.93	0.71	0.20	0.41	0.71
transitional-cell carcinoma cell line:JMSU1	10492-107B6	12.06	0.63	2.35	0.94	0.78	0.47
tridermal teratoma cell line:HGRT	10694-109G1	34.25	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	68.99	19.47	4.49	2.12	2.20	1.44
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	14.50	2.56	1.37	0.17	0.51	0.17
uterus, fetal, donor1	10055-101H1	15.87	2.05	3.07	1.02	0.51	0.00
vagina, adult	10204-103F6	30.37	2.58	3.88	2.58	1.29	0.00
vein, adult	10191-103E2	34.63	3.51	3.73	2.63	2.19	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.82	0.80	1.60	0.00	0.27	0.27